This company has been marked as potentially delisted and may not be actively trading. Sigilon Therapeutics (SGTX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock SGTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Lilly & Co Eli's Net WorthMay 1, 2024 | benzinga.comMCRB Seres Therapeutics, Inc.April 14, 2024 | seekingalpha.comBeam Therapeutics Inc.October 22, 2023 | wsj.comWhy These 3 Large Caps Are Bucking the August Slump (SGTX)The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023.August 22, 2023 | marketbeat.comEli Lilly Concludes Acquisition Of Sigilon TherapeuticsAugust 14, 2023 | markets.businessinsider.comLilly Completes Acquisition of Sigilon TherapeuticsAugust 14, 2023 | finance.yahoo.comSigilon Therapeutics (Nasdaq:SGTX) HeadlineTrading was temporarily halted for "SGTX" at 07:08 PM with a stated reason of "News pending."...August 11, 2023 | marketbeat.comSGTX - Sigilon Therapeutics, Inc.August 1, 2023 | finance.yahoo.comInside Eli Lilly's Strategic Investment In Sigilon: An Opportunity OverlookedJuly 31, 2023 | msn.comSIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon ...July 21, 2023 | businesswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMC, SGTX, AJX, IMNMJuly 18, 2023 | markets.businessinsider.comCanaccord Genuity Maintains Sigilon Therapeutics (SGTX) Buy RecommendationJuly 6, 2023 | msn.comSigilon Therapeutics (SGTX) Price Target Decreased by 6.27% to 48.28July 6, 2023 | msn.com5 big deal reports: Overstock snags Bed Bath & Beyond IP; Visa pays $1B for PismoJuly 3, 2023 | msn.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Sigilon Therapeutics, Inc. BuyoutJune 29, 2023 | benzinga.comModerna Billionaire Set to Score 3,000% Gain on Tiny BiotechJune 29, 2023 | finance.yahoo.comEli Lilly and Company: Lilly to Acquire Sigilon TherapeuticsJune 29, 2023 | finanznachrichten.deHealth Care Company Eli Lilly Announces Acquisition of Sigilon TherapeuticsJune 29, 2023 | msn.comSigilon stock up 500% on Lilly acquisition newsJune 29, 2023 | bizjournals.comSigilon Therapeutics Shares Are Shooting Higher Today - What's Going OnJune 29, 2023 | finance.yahoo.comSigilon Therapeutics (Nasdaq:SGTX) HeadlineTrading was temporarily halted for "SGTX" at 09:06 AM with a stated reason of "LULD pause."...June 29, 2023 | marketbeat.comSigilon stock skyrockets 650% on buyout deal with Eli LillyJune 29, 2023 | msn.comEli Lilly To Acquire Sigilon TherapeuticsJune 29, 2023 | markets.businessinsider.comWhy Is Sigilon Therapeutics (SGTX) Stock Up 691% Today?June 29, 2023 | msn.comSGTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Sigilon Therapeutics, Inc. Is Fair to ShareholdersJune 29, 2023 | technews.tmcnet.comLilly to Acquire Sigilon TherapeuticsJune 29, 2023 | finance.yahoo.comEli Lilly to buy Sigilon Therapeutics to expand diabetes treatmentsJune 29, 2023 | finance.yahoo.comMorgan Stanley Sticks to Their Hold Rating for Sigilon Therapeutics (SGTX)May 26, 2023 | markets.businessinsider.comMorgan Stanley Maintains Sigilon Therapeutics (SGTX) Equal-Weight RecommendationMay 25, 2023 | msn.comSigilon Therapeutics's Return On Capital Employed OverviewMay 24, 2023 | msn.comSigilon Therapeutics (Nasdaq:SGTX) HeadlineTrading was temporarily halted for "SGTX" at 11:05 AM with a stated reason of "LULD pause."...May 23, 2023 | marketbeat.comSigilon Therapeutics, Inc.: Sigilon Announces Reverse Stock Split of Common StockMay 22, 2023 | finanznachrichten.deSigilon Therapeutics Announces One-for-13 Reverse Stock Split - Quick FactsMay 22, 2023 | markets.businessinsider.comSigilon Therapeutics to effect 13-for-1 reverse stock splitMay 22, 2023 | msn.comSigilon Announces Reverse Stock Split of Common StockMay 22, 2023 | finance.yahoo.comSigilon Therapeutics, Inc.: Sigilon Therapeutics Reports First Quarter 2023 Financial Results and Business HighlightsMay 9, 2023 | finanznachrichten.deSigilon Therapeutics GAAP EPS of -$0.23 in-line, revenue of $4.86M beats by $1.76MMay 9, 2023 | msn.comSigilon Therapeutics to Present at the Needham Virtual Healthcare ConferenceApril 18, 2023 | finance.yahoo.comRevenues Working Against Sigilon Therapeutics, Inc.'s (NASDAQ:SGTX) Share Price Following 34% DiveApril 17, 2023 | finance.yahoo.comSigilon Therapeutics, Inc.: Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsMarch 15, 2023 | finanznachrichten.deSigilon Therapeutics GAAP EPS of -$0.21 beats by $0.17, revenue of $2.64M misses by $0.03MMarch 14, 2023 | msn.comSigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsMarch 14, 2023 | finance.yahoo.comSigilon Therapeutics (Nasdaq:SGTX) HeadlineTrading was temporarily halted for "SGTX" at 10:03 AM with a stated reason of "LULD pause."...March 14, 2023 | marketbeat.comShort Volatility Alert: Sigilon TherapeuticsFebruary 28, 2023 | benzinga.comWhy Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving PremarketJanuary 19, 2023 | msn.comSigilon Therapeutics Third Quarter 2022 Earnings: Beats ExpectationsNovember 12, 2022 | finance.yahoo.comSigilon Therapeutics, Inc.: Sigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business HighlightsNovember 10, 2022 | finanznachrichten.deSigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business HighlightsNovember 10, 2022 | finance.yahoo.comSigilon Therapeutics, Inc. (SGTX) Reports Q3 Loss, Tops Revenue EstimatesNovember 10, 2022 | finance.yahoo.comDelix Therapeutics Expands World-Class Team with First Head of R&DSeptember 24, 2022 | finance.yahoo.com Get Sigilon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SGTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SGTX Media Mentions By Week SGTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGTX News Sentiment▼0.000.69▲Average Medical News Sentiment SGTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGTX Articles This Week▼00▲SGTX Articles Average Week Get the Latest News and Ratings for SGTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Sigilon Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CYBN News Today VIRI News Today OSTX News Today ELYM News Today ATNM News Today AADI News Today EGRX News Today PYRGF News Today NNVC News Today IBIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGTX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersMusk Warns. Trump Acts. Your Retirement May Depend on ItWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sigilon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sigilon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
